Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 236

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Genetic modifiers of risk and age at onset in GBA associated Parkinson’s disease and Lewy body dementia

Open access
Blauwendraat, Cornelis, Reed, Xylena, Krohn, Lynne, Heilbron, Karl, Bandres-Ciga, Sara, Tan, Manuela, Gibbs, J Raphael, Hernandez, Dena G, Kumaran, Ravindran, Langston, Rebekah, Bonet-Ponce, Luis, Alcalay, Roy N, Hassin-Baer, Sharon, Greenbaum, Lior, Iwaki, Hirotaka, Leonard, Hampton L, Grenn, Francis P, Ruskey, Jennifer A, Sabir, Marya, Ahmed, Sarah, Makarious, Mary B, Pihlstrøm, Lasse, Toft, Mathias, van Hilten, Jacobus J, Marinus, Johan, Schulte, Claudia, Brockmann, Kathrin, Sharma, Manu, Siitonen, Ari, Majamaa, Kari, Eerola-Rautio, Johanna, Tienari, Pentti J, The 23andMe Research Team, Pantelyat, Alexander, Hillis, Argye E, Dawson, Ted M, Rosenthal, Liana S, Albert, Marilyn S, Resnick, Susan M, Ferrucci, Luigi, Morris, Christopher M, Pletnikova, Olga, Troncoso, Juan, Grosset, Donald, Lesage, Suzanne, Corvol, Jean-Christophe, Brice, Alexis, Noyce, Alastair J, Masliah, Eliezer, Wood, Nick, Hardy, John, Shulman, Lisa M, Jankovic, Joseph, Shulman, Joshua M, Heutink, Peter, Gasser, Thomas, Cannon, Paul, Scholz, Sonja W, Morris, Huw, Cookson, Mark R, Nalls, Mike A, Gan-Or, Ziv, Singleton, Andrew B · 2020 · Brain

Abstract

Parkinson’s disease is a genetically complex disorder. Multiple genes have been shown to contribute to the risk of Parkinson’s disease, and currently 90 independent risk variants have been identified by genome-wide association studies. Thus far, a number of genes (including SNCA, LRRK2, and GBA) have been shown to contain variability across a spectrum of frequency and effect, from rare, highly penetrant variants to common risk alleles with small effect sizes. Variants in GBA, encoding the enzyme glucocerebrosidase, are associated with Lewy body diseases such as Parkinson’s disease and Lewy body dementia. These variants, which reduce or abolish enzymatic activity, confer a spectrum of disease risk, from 1.4- to >10-fold. An outstanding question in the field is what other genetic factors that influence GBA-associated risk for disease, and whether these overlap with known Parkinson’s disease risk variants. Using multiple, large case-control datasets, totalling 217 165 individuals (22 757 Parkinson’s disease cases, 13 431 Parkinson’s disease proxy cases, 622 Lewy body dementia cases and 180 355 controls), we identified 1691 Parkinson’s disease cases, 81 Lewy body dementia cases, 711 proxy cases and 7624 controls with a GBA variant (p.E326K, p.T369M or p.N370S). We performed a genome-wide association study and analysed the most recent Parkinson’s disease-associated genetic risk score to detect genetic influences on GBA risk and age at onset. We attempted to replicate our findings in two independent datasets, including the personal genetics company 23andMe, Inc. and whole-genome sequencing data. Our analysis showed that the overall Parkinson’s disease genetic risk score modifies risk for disease and decreases age at onset in carriers of GBA variants. Notably, this effect was consistent across all tested GBA risk variants. Dissecting this signal demonstrated that variants in close proximity to SNCA and CTSB (encoding cathepsin B) are the most significant contributors. Risk variants in the CTSB locus were identified to decrease mRNA expression of CTSB. Additional analyses suggest a possible genetic interaction between GBA and CTSB and GBA p.N370S induced pluripotent cell-derived neurons were shown to have decreased cathepsin B expression compared to controls. These data provide a genetic basis for modification of GBA-associated Parkinson’s disease risk and age at onset, although the total contribution of common genetics variants is not large. We further demonstrate that common variability at genes implicated in lysosomal function exerts the largest effect on GBA associated risk for disease. Further, these results have implications for selection of GBA carriers for therapeutic interventions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/brain/awz350

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 236

Metadata

Authors
Blauwendraat, C., Reed, X., Krohn, L., Heilbron, K., Bandres-Ciga, S., Tan, M., Gibbs, J. R., Hernandez, D. G., Kumaran, R., Langston, R., Bonet-Ponce, L., Alcalay, R. N., Hassin-Baer, S., Greenbaum, L., Iwaki, H., Leonard, H. L., Grenn, F. P., Ruskey, J. A., Sabir, M., Ahmed, S., Makarious, M. B., Pihlstrøm, L., Toft, M., van Hilten, J. J., Marinus, J., Schulte, C., Brockmann, K., Sharma, M., Siitonen, A., Majamaa, K., Eerola-Rautio, J., Tienari, P. J., The 23andMe Research Team, Pantelyat, A., Hillis, A. E., Dawson, T. M., Rosenthal, L. S., Albert, M. S., Resnick, S. M., Ferrucci, L., Morris, C. M., Pletnikova, O., Troncoso, J., Grosset, D., Lesage, S., Corvol, J.-C., Brice, A., Noyce, A. J., Masliah, E., Wood, N., Hardy, J., Shulman, L. M., Jankovic, J., Shulman, J. M., Heutink, P., Gasser, T., Cannon, P., Scholz, S. W., Morris, H., Cookson, M. R., Nalls, M. A., Gan-Or, Z., & Singleton, A. B.
Venue
Brain
Published
2019-11-22
Volume
143
Issue
1
Pages
234-248
ISSN
  • 0006-8950 (ISSN-L)
  • 1460-2156
OpenAlex
W2993040769
Cited by
236
References
16
FWCI
16.29
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genetic modifiers of risk and age at onset in GBA associated Parkinson’s disease and Lewy body dementia. https://app.cochat.ai/papers/10.1093/brain/awz350
The paper
Blauwendraat, C., Reed, X., Krohn, L., Heilbron, K., Bandres-Ciga, S., Tan, M., Gibbs, J. R., Hernandez, D. G., Kumaran, R., Langston, R., Bonet-Ponce, L., Alcalay, R. N., Hassin-Baer, S., Greenbaum, L., Iwaki, H., Leonard, H. L., Grenn, F. P., Ruskey, J. A., Sabir, M., . . . Singleton, A. B. (2020). Genetic modifiers of risk and age at onset in GBA associated Parkinson’s disease and Lewy body dementia. Brain. https://doi.org/10.1093/brain/awz350

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.